One decade of improving palliative care of metastatic renal cell carcinoma by antiangiogenic therapies: time to move toward RCC cure. [electronic resource]
- International journal of cancer Apr 2015
- 1483-4 p. digital
Publication Type: Editorial
1097-0215
10.1002/ijc.29189 doi
Angiogenesis Inhibitors--therapeutic use Antineoplastic Agents--therapeutic use Carcinoma, Renal Cell--drug therapy Humans Kidney Neoplasms--drug therapy Palliative Care